Literature DB >> 19818731

Adrm1 interacts with Atp6v0d2 and regulates osteoclast differentiation.

Taesoo Kim1, Hyun-Il Ha, Nacksung Kim, Okju Yi, Seoung Hoon Lee, Yongwon Choi.   

Abstract

Bone homeostasis is tightly regulated by matrix-producing osteoblasts and bone-resorbing osteoclasts. During osteoclast development, mononuclear preosteoclasts derived from myeloid cells fuse together to form multinucleated, giant cells. Previously, we reported that the d2 isoform of the vacuolar (H(+)) ATPase V0 domain (Atp6v0d2) plays an important role in osteoclast maturation and bone formation. To understand how Atp6v0d2 controls osteoclast maturation, we have performed a yeast two-hybrid screen using full-length Atp6v0d2 as the bait, and identified adhesion-regulating molecule 1 protein (Adrm1) as a potential functional partner of Atp6v0d2. The interaction between Atp6v0d2 and Adrm1 was confirmed in yeast and invivo using immunoprecipitation assays. We also show that Adrm1 is required for cell migration and osteoclast maturation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818731      PMCID: PMC2788059          DOI: 10.1016/j.bbrc.2009.10.010

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

Review 1.  The vacuolar (H+)-ATPases--nature's most versatile proton pumps.

Authors:  Tsuyoshi Nishi; Michael Forgac
Journal:  Nat Rev Mol Cell Biol       Date:  2002-02       Impact factor: 94.444

Review 2.  Osteoimmunology: interplay between the immune system and bone metabolism.

Authors:  Matthew C Walsh; Nacksung Kim; Yuho Kadono; Jaerang Rho; Soo Young Lee; Joseph Lorenzo; Yongwon Choi
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

3.  Adhesion properties of adhesion-regulating molecule 1 protein on endothelial cells.

Authors:  Nathalie Lamerant; Claudine Kieda
Journal:  FEBS J       Date:  2005-04       Impact factor: 5.542

Review 4.  Structure, function and regulation of the vacuolar (H+)-ATPase.

Authors:  T H Stevens; M Forgac
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

Review 5.  Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.

Authors:  T Suda; N Takahashi; N Udagawa; E Jimi; M T Gillespie; T J Martin
Journal:  Endocr Rev       Date:  1999-06       Impact factor: 19.871

6.  Functional cloning of ARM-1, an adhesion-regulating molecule upregulated in metastatic tumor cells.

Authors:  A B Simins; H Weighardt; K M Weidner; U H Weidle; B Holzmann
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

7.  Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration.

Authors:  Han Bok Kwak; Soo Woong Lee; Hye Mi Jin; Hyunil Ha; Sang Ho Lee; Sunao Takeshita; Sakae Tanaka; Hyun-Man Kim; Hong-Hee Kim; Zang Hee Lee
Journal:  Blood       Date:  2004-12-07       Impact factor: 22.113

8.  An inducible nitric-oxide synthase (NOS)-associated protein inhibits NOS dimerization and activity.

Authors:  E A Ratovitski; C Bao; R A Quick; A McMillan; C Kozlovsky; C J Lowenstein
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

9.  Molecular cloning and characterization of the complementary DNA of an M(r) 110,000 antigen expressed by human gastric carcinoma cells and upregulated by gamma-interferon.

Authors:  S Shimada; M Ogawa; M Takahashi; J Schlom; J W Greiner
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

10.  Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption.

Authors:  Haiping Wu; Guoliang Xu; Yi-Ping Li
Journal:  J Bone Miner Res       Date:  2009-05       Impact factor: 6.741

View more
  7 in total

1.  Oxaliplatin reverses the GLP-1R-mediated promotion of intrahepatic cholangiocarcinoma by altering FoxO1 signaling.

Authors:  Bendong Chen; Wenyan Zhou; Wenchao Zhao; Peng Yuan; Chaofeng Tang; Genwang Wang; Junzhi Leng; Jinlong Ma; Xiaowen Wang; Yongfeng Hui; Qi Wang
Journal:  Oncol Lett       Date:  2019-06-19       Impact factor: 2.967

2.  Impact of cigarette smoke on the human and mouse lungs: a gene-expression comparison study.

Authors:  Mathieu C Morissette; Maxime Lamontagne; Jean-Christophe Bérubé; Gordon Gaschler; Andrew Williams; Carole Yauk; Christian Couture; Michel Laviolette; James C Hogg; Wim Timens; Sabina Halappanavar; Martin R Stampfli; Yohan Bossé
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

3.  hRpn13, a newly identified component of the 19S particle, regulates proliferation, differentiation, and function in the human osteoblast-like cell line MG63. [corrected].

Authors:  Xi Zhao; Yonglie Chao; Pixiu Chen; Die Liu; Peng Su; Jian Sun; Xuqin Cui; Yaxiong Tang
Journal:  J Physiol Biochem       Date:  2011-11-05       Impact factor: 4.158

4.  Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.

Authors:  Mari Okayasu; Mai Nakayachi; Chiyomi Hayashida; Junta Ito; Toshio Kaneda; Masaaki Masuhara; Naoto Suda; Takuya Sato; Yoshiyuki Hakeda
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

5.  Establishing an osteosarcoma associated protein-protein interaction network to explore the pathogenesis of osteosarcoma.

Authors:  Bi-Yong Deng; Ying-Qi Hua; Zheng-Dong Cai
Journal:  Eur J Med Res       Date:  2013-12-14       Impact factor: 2.175

Review 6.  Osteoclast Multinucleation: Review of Current Literature.

Authors:  Joe Kodama; Takashi Kaito
Journal:  Int J Mol Sci       Date:  2020-08-08       Impact factor: 5.923

7.  Ubiquitin Receptor RPN13 Mediates the Inhibitory Interaction of Diphenyldihaloketones CLEFMA and EF24 With the 26S Proteasome.

Authors:  Geeta Rao; Gregory Nkepang; Jian Xu; Hooman Yari; Hailey Houson; Chengwen Teng; Vibhudutta Awasthi
Journal:  Front Chem       Date:  2018-09-10       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.